HPLC investigated physicochemical compatibility between Artrosilene injectable solution and other pharmaceutical products frequently used for combined therapy into elastomeric Baxter LV5 infusion devices.

International journal of immunopathology and pharmacology

Volumn 18, Issue 4, 2005, Pages 791-798

  Anacardio, R ^a   Bartolini, S ^a   Gentile, M M ^a   Bagnasco, M ^a   Carlucci, G ^a  

^a Chemistry Section   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ELASTOMER; KETOPROFEN; KETOPROFEN LYSINE; KETOROLAC TROMETAMOL; LYSINE; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRAMADOL;

ARTICLE; CHEMISTRY; COLOR; DRUG COMBINATION; DRUG INCOMPATIBILITY; DRUG PACKAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFUSION PUMP; PH; PHYSICAL CHEMISTRY; SOLUTION AND SOLUBILITY;

ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLOR; DRUG COMBINATIONS; DRUG INCOMPATIBILITY; DRUG PACKAGING; ELASTOMERS; HYDROGEN-ION CONCENTRATION; INFUSION PUMPS; KETOPROFEN; KETOROLAC TROMETHAMINE; LYSINE; MORPHINE; PHARMACEUTICAL SOLUTIONS; TRAMADOL;

EID: 33644869665     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800423     Document Type: Article

References (0)